IQV vs PATH · P/E 23, rev $15.40B vs P/E 19, rev $1.61B
IQVIA Holdings Inc (IQV) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IQV and PATH stock pages for the full models.
Not investment advice.